GP Vivas · addiction-medicine
Alcohol use disorder — structured viva
Structured oral on alcohol use disorder: AUDIT screening and brief intervention, naltrexone and acamprosate pharmacotherapy with JAMA meta-analysis data, alcohol withdrawal management, Wernicke encephalopathy prevention, and the GP role in long-term recovery.
On this page
Study tools
Target exams
RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'AUD patients never change — why waste your time?' The viva branches through screening, brief intervention evidence, pharmacotherapy with NNT data, withdrawal management, Wernicke prevention, and the GP role in recovery.
Stem
A colleague says AUD treatment is futile because patients always relapse. You are asked to present the evidence. [1]
References2ShowHide
- [1]Plosker GL Acamprosate: A Review of Its Use in Alcohol Dependence. Drugs, 2015.PMID 26084940
- [4]Morley KC, Kranzler HR, Luquin N, Jamshidi N, Adams C, et al. Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial. Am J Psychiatry, 2024.PMID 38706338